Skip to main content

Your search for “Hepatology” returned 42 results

Father’s Life is Saved after Receiving Heart, Kidney and Liver Transplant

September 8, 2022

After a rare disease caused organ failure, UC San Diego Heath transplant teams performed a heart, liver and kidney transplant on a patient. The surgery is a first for UC San Diego Health and a first in the nation to use three organs from a donor after circulatory death.

Diet Plays Critical Role in NASH Progressing to Liver Cancer in Mouse Model

June 1, 2021

Researchers at University of California San Diego School of Medicine found in a mouse model that when fed a Western diet rich in calories, fat and cholesterol, the mice progressively became obese, diabetic and developed NASH, which progressed to HCC, chronic kidney and cardiovascular disease.

Gastrointestinal Hormone Measurably Improved Symptoms of Non-Alcoholic Fatty Liver Disease

March 8, 2018

Through a randomized, double-blind, placebo-controlled phase II clinical trial, researchers at University of California San Diego School of Medicine report that small doses of NGM282, a non-tumorigenic variant of an endocrine gastrointestinal hormone, can significantly and rapidly decrease liver fat content in patients with non-alcoholic fatty liver disease (NAFLD) and…

Technique May Identify Patients with Fast-Progressing Fibrosis in Nonalcoholic Fatty Liver Disease

October 11, 2016

Combining multiple non-invasive measures, researchers at University of California San Diego School of Medicine describe a novel method to quantify the progression of nonalcoholic fatty liver disease (NAFLD) to its more dangerous and deadly states — advanced fibrosis and cirrhosis.

First in Nation: UC San Diego Health Offers Treatment for Hereditary Amyloidosis

August 18, 2022

New medication now available at UC San Diego Health allows for less frequent visits for patients, helping improve quality of life.

To Ward off Fatty Liver, Breast is Best for Mom

November 1, 2018

Researchers at University of California San Diego School of Medicine and Kaiser Permanente have discovered that mothers who breastfed a child or children for six months or more are at lower risk for developing non-alcoholic fatty liver disease (NAFLD) years later during mid-life. With no other current prevention options aside…

Stress-Tolerant Cells Drive Tumor Initiation in Pancreatic Cancer

January 17, 2023

UC San Diego scientists discover a molecular pathway critical to the initiation of pancreatic tumors. The findings may inspire new chemotherapeutic drugs targeting early stages of tumor formation and spread

A New Strategy to Transform Liver Cancer Immunotherapy

December 7, 2021

UC San Diego researchers identify new strategy to improve efficacy of immunotherapy on resistant liver cancers.

Novel Anti-Malarial Drug Target Identified

July 19, 2012

An international team of scientists, led by researchers from the department of pediatrics at the UC San Diego School of Medicine, have identified the first reported inhibitors of a key enzyme involved in survival of the parasite responsible for malaria. Their findings, which may provide the basis for anti-malarial drug…

MAGNET Study Sees Potential for MRE in Measuring Liver Fibrosis in Children

May 11, 2017

Researchers at University of California San Diego School of Medicine, with collaborators across the nation, have determined that magnetic resonance elastography (MRE) can be an accurate, non-invasive tool to identify liver fibrosis in children. Nonalcoholic fatty liver disease (NAFLD) is now the most common cause of chronic liver disease in…

Category navigation with Social links